Comparing Renal Biomarkers and Utility to Monitor Immunosuppression - Couverture souple

Muhammad, Shahid

 
9783659835711: Comparing Renal Biomarkers and Utility to Monitor Immunosuppression
Couverture souple
ISBN 10 : 3659835714 ISBN 13 : 9783659835711
Editeur : LAP LAMBERT Academic Publishing, 2016

Synopsis

Chronic Kidney Disease (CKD) is on the rise in all ethnicities. Evidence also highlights that this disease negatively impacts quality of life and places an enormous financial implications on the health care system for the provision of care to patients. Thus, it is of utmost importance to devise strategies that prevent CKD and delay progressive loss of renal function in the wider population. Biomedical scientists now have a more active and larger role to play with respect to monitoring. Whilst there have been guidelines on the screening and monitoring of anticoagulation-based medication, there perhaps needs to be more collaborative guidelines to monitor mainstay IST post-transplant patients receive. Specialists from both clinical and laboratory practice need to come together to further inform which biomarkers would be specific for monitoring IST titres. Individuals who are at high risk of CKD need better ‘preparation’ and prompt early referral to secondary care is a must in order to allow the best prognosis. In addition, the utility of biomarkers for monitoring post-transplant immunosuppression has to become more specific for patients post-transplant.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Présentation de l'éditeur

Chronic Kidney Disease (CKD) is on the rise in all ethnicities. Evidence also highlights that this disease negatively impacts quality of life and places an enormous financial implications on the health care system for the provision of care to patients. Thus, it is of utmost importance to devise strategies that prevent CKD and delay progressive loss of renal function in the wider population. Biomedical scientists now have a more active and larger role to play with respect to monitoring. Whilst there have been guidelines on the screening and monitoring of anticoagulation-based medication, there perhaps needs to be more collaborative guidelines to monitor mainstay IST post-transplant patients receive. Specialists from both clinical and laboratory practice need to come together to further inform which biomarkers would be specific for monitoring IST titres. Individuals who are at high risk of CKD need better ‘preparation’ and prompt early referral to secondary care is a must in order to allow the best prognosis. In addition, the utility of biomarkers for monitoring post-transplant immunosuppression has to become more specific for patients post-transplant.

Biographie de l'auteur

Shahid is a Specialist Biomedical Scientist, a member of the Institute of Biomedical Sciences (MIBMS), a member of the British Blood and Transfusion Society (BBTS), a registered Scientist under the Science Council (RSci) and a member of the Healthcare Professionals Council (HCPC). Shahid writes to join efforts in care of patients in CKD.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Éditeur
LAP LAMBERT Academic Publishing
Date d'édition
2016
Langue
anglais
ISBN 10 
3659835714
ISBN 13 
9783659835711
Reliure
Broché
Nombre de pages
60
Coordonnées du fabricant
non disponible
Personne responsable
KreGa Onlinehandel GmbH
4950000000000
info@krega-onlinehandel.de

Birkenweg 31
Brakel
33034
Allemagne